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In previous studies, Zingiber officinale, Piper retrofractum, and the combination showed cytotoxic activity,
induced apoptosis, and p53 expression of HeLa, T47D, and MCF-7 cell lines. This study was conducted to investigate
the cytotoxic and apoptotic activity of Zingiber officinale (ZO), Piper retrofractum (PR), and the combination as
well as their effect to p53 expression on Myeloma and WiDr cells. The powder of ZO, PR, and ZO + PR combination
(1:1) were macerated with 96% ethanol for 3 x 24 hours. MTT cytotoxic assay was performed on Myeloma and
WiDr cell lines. Apoptotic cells were stained with ethidium bromide and acridine orange. Imunohistochemical
expression of p53 was examined on Myeloma and WiDr cell lines. Doxorubicin was used as positive control in all
assays. Results showed that ZO, PR, and ZO + PR combination had cytotoxic activity on Myeloma cells with IC50
of 28, 36, and 55 mg/ml respectively and WiDr cell lines with IC50 of 74, 158, and 64 mg/ml respectively, induced
apoptotic activity, and increased p53 expression on Myeloma and WiDr cells. These results suggest that ZO, PR,
and their combination induced Myeloma and WiDr cells in apoptosis through p53 expression.
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INTRODUCTION
Indonesia has a diversity of plant species with a
potential for being medicinal plants. Two of these medicinal
plants are red ginger (Zingiber officinale. var.rubrum) and
javanese chili (Piper retrofractum).
Piperin (bioactive compound of P. retrofractum) and
6-gingerol (bioactive compound of Z. officinale) suppress
inflammatory processes that lead to transformation,
hyperproliferation, and initiation of carcinogenesis
(Aggarwal & Shishodia 2006). Research, both in vitro and
in vivo, has been done on Z. officinale and P. retrofractum.
According to Habib et al. (2008), ZO can be used as an
anti-cancer and anti-inflammatory by inhibiting Nuclear
Factor kappa B (NFκB) and signaling the arrival of Tumor
Necrosis Factor-α (TNF-α). Ginger extract inhibit cell
proliferation of HCT 116 and HT 29 with IC50 of 496 ± 34.2
µg/ml and 455 ± 18.6 μg/ml (Abdullah et al. 2010). While
PR has benefits as an analgesic and antioxidant, there is
study reporting that javanese chili has a toxic effect
against myeloma cells with IC50 of 55.48 μg/ml (Setyorini
2007). Wicaksono et al. (2009) stated that the methanol
extract of Piper crocatum Ruiz and Pav leaves have the
ability to inhibit T47D cells at IC50 44.25 μg/ml in vitro.
The study of cancer treatment by combining several plants
has been done in Thailand, with a herbal medicine called
Pikutbenjakul. Sakpakdeejaroen and Itharat (2009) reported
that the cytotoxic activity of Piper Chaba, Zingiber
officinale, and Pikutbenjakul (Piper Chaba, Piper
sarmentosum, Piper interruptum, Plumbago indica, and
Zingiber officinale) against breast adenocarcinoma cells
(MCF-7) obtained IC50 Piper Chaba, Zingiber officinale,
and Pikutbenjakul were 35.17; 31.15; and 33.20 μg/ml
respectively.
The research on ZO, PR, and their combination for
anticancer agent in myeloma and WiDr cancer cell has not
been done. This research observed cytotoxic and apoptotic
activity of ZO, PR, and its combination and their effect to
p53 gene on Myeloma and WiDr cells.
MATERIALS  AND  METHODS
Plant Materials, Chemicals, Cell Line, and Culture.
Z.offinale rhizome and P. Refractum were obtained from
the local market, authenticated, and stored in the
Taxonomy Laboratory at the Biology Faculty of Jenderal
Soedirman University. Doxorubicin was obtained from the
Parasite Laboratory, Faculty of Medicine, Gadjah Mada
University. Myeloma and WiDr cancer cells were obtained
from Parasite Laboratory, Faculty of Medicine, Gadjah
Mada University. Cultured myeloma was first taken from
Merwin Plasma Tumor Cells-11 (MPC-11) isolated from
murine Balb/c collection of J. Fahey in 1967. These
myeloma cells resembled the parent tumor cells that
produce IgG2b 5-6 g each cell/minute with a time division
of approximately 17 hours (Terpos 2005). WiDr is a colon
cancer cell in humans that was isolated from the colonic
epithelial tissue of a 78-year-old woman (Chen et al. 1987).
WiDr carsinoembryonic produce antigens and requires
about 15 hours to be able to complete one cell cycle. One
of the characteristics of WiDr cells is overexpression of
cyclooxygenase-2 (COX-2) (Palozza et al. 2005). Myeloma
and WiDr cells were routinely cultured in RPMI 1640
medium (Sigma) and supplemented with 10% Fetal Bovine
Serum (FBS) (Sigma-Aldrich, USA) at 37 oC in a 5% CO2
atmosphere, 3% penicillin- streptomycin, and 1%
fungizone. Subcultures were obtained after treatment with
0.05% trypsin (Gibco, Auckland) in phosphate buffer saline
(PBS).
Preparation of Extract Combination ZO and PR were
washed, cut into pieces, dried and crushed into powder.
400 g of ZO rhizome powder, 400 g of PR and combination
of ZO:PR = 1:1 (one each 200 g) were extracted by
maceration using 96% ethanol for 3 x 24 hours. The extract
was filtered and then evaporated.
Cell Viability Assay: 3-(4,5-Dimethylthiazol-2-yl)-
2,5-Diphenyl Tetrazolium Bromide (MTT) Assay. For cell
viability assay, 1.5 × 104 cells/well were plated in 100 μl of
culture media. Cells were incubated overnight at 37 oC in a
humidified atmosphere of 5% CO2 for cells attachment.
Extracts were added at various concentrations ranging
from 500 to 7.81 μg/ml. After 24 hours incubation, 10 μl of
MTT solution (MTT reagent in 5 mg/ml PBS) was added
to the plate. The resulting MTT-products were determined
by measuring the absorbance at 595 nm with ELISA
(Mosmann 1983).
Determination of Apoptosis. Myeloma and WiDr cells
were grown on glass coverslips in tissue culture dishes
(Falcon) and were allowed to attach for 24 hours prior to
the addition of any drug. After the cells were incubated
with a drug for 24 hours, the coverslips were washed once
in PBS and fixed in object glass. Treated cells were stained
with acridine orange and ethidium bromide 5 μl and
visualized by fluoresence microscopy (Mosmann 1983).
Determination of p53. WiDr cancer cells were cultured
in 24-well plates (Nalge Nunc International, Denmark) at a
density of 1.5 × 105 cells per well and incubated for 24
hours. The cells were then treated with 1 x IC50, 0.5 x IC50,
0.25 x IC50 concentrations of combination extract and
doxorubisin. After 24 hours, cells were plated in poly-L-
Lisin slides. Cells were fixed with methanol (pro analysis)
for 5 minutes, permeabilized for 5 minutes in PBS
containing 0.2% Triton X-100, blocked in 2% BSA for 1
hour, and stained with the monoclonal antibody p53 (1:400)
for 1 hour. It was then washed with PBS for 3 x 5 minutes
and stained with bionylated secondary antibody for 1
hour. Next, it was incubated in HRP-streptavidin for 10
minutes, added DAB for 5 minutes, washed with aquadest,
Counterstained with Harry’s hematoxylin for 20 seconds,
and mounted on glass slides.
RESULTS
ZO, PR, and the combination extract had cytotoxic
activity on myeloma cells with IC50 values of 28, 36, and 55
μg/ml respectively. In this study, doxorubicin inhibited
cells with IC50 values of 2 μg/ml (Figure 1).  ZO, PR, and
the combination extract also had cytotoxic activity against
the cancer cell WiDr. This was indicated by the IC50 value
of 74 and 158 μg/ml respectively. The combination extracts
have cytotoxic activity with IC50 value of 64 μg/ml and
doxorubicin 1 μg/ml (Figure 1).The apoptosis assay results
being viewed under a microscope are shown in Figure 2.
Results showed there was no apoptosis activity in
myeloma and WiDr cell control (Figure 2a,e) shown as
green cells. Myeloma cells that were treated with extract
(Figure 2b,c,d), resulted in an orange color. This showed
that the treated cells were induced into apoptosis. WiDr
cells that were treated with extract (Figure 2f,g,h), resulted
in an orange colour. This indicated that the cells were
induced into apoptosis.
P53 imunocytochemistry of treated cells can be
determined qualitatively from the figure in the microscope
(Figure 3). Cells that express p53 protein are marked with
brown cell nuclei and cells that do not express the p53
protein are marked with a purple nucleus. P53 protein
expression results are viewed under a microscope.
DISCUSSION
Figure 1 showed that the extracts had cytotoxic activity
on Myeloma and WiDr cells, as shown by the IC50 value.
This indicated that the extract had cytotoxic activity
against Myeloma and WiDr cells. Meyer et al. (1982)
declared that the extracts have anticancer activity if the
IC50 value were less than 1000 μg/ml after 24 hours of
contact time. The smaller the IC50 of a compound, the more
toxic the compound = was (Doyle & Griffiths 2000).
Merging or combining several plants in cancer
treatment was performed to enhance the cytotoxic activity
and minimize side effects caused by the use of anticancer
drugs (Beinfield & Kornglod 2005;Sapakdeejaroen &
Itharat 2009). Cytotoxic activity of the combination extract
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Figure 1. IC50 of Z. Officinale (ZO), P. retrofractum (PR), extract
combination and doxorubicin (DOX) on Myeloma and
WiDr cancer cells. Cells were treated with various doses
of ZO, PR, extract combination and DOX, incubated
for 24 hours at 37 oC in humidified 5% CO2 atmosphere.
Cell viability was determined by MTT assay, absorbance
was read at 595 nm. Concentrations inhibiting 50% of
the cell were determined by probit analysis using SPSS
software. : Myeloma, : WiDr
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against WiDr cells was higher with an IC50 value of 64 μg/
ml compared with IC50 values of each individual extract,
specifically 74 and 158 μg/ml for ZO and PR extracts
respectively. In Myeloma cells, the combination extract
has an IC50 value of 55 μg/ml. This was caused by the
different mechanisms of ZO and PR against cancer. ZO
could raise natural killer cell activity (NK) to lyse target
cells, namely tumor cells and virus-infected cells and was
able to inhibit the activity of NFκB through the inhibition
of cytokine pro-inflammation (Hudson et al. 2000; Habib
et al. 2008). Research carried out by Rhode et al. (2007)
showed that ZO extract inhibited cell growth and
modulated secretion of angiogenic factor in ovarian cancer
cells. Another study carried out on liver cancer showed
that ZO inhibited the activation of CD8+ T cells (Suzuki et
al. 1997; Habib et al. 2008). NFκB is a stimulant in the form
of signals that can activate normal cells, causing
inflammation and carcinogenesis (Lin & Karin 2003; Philip
et al. 2004). The existence of this NFκB may lead to new
agents that are TNF-α. TNF-α is the cause of the
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Figure 2. Apoptosis activity of Z. Officinale(ZO), P. retrofractum (PR) and extract combination. Cells were treated with acridine orange
and ethidium bromide. All cells in the control were in a green color. In the treatment  with ZO, PR and its combination extract,
most cells were in a green color and some were in an orange color. Green color showed viable cells (blue arrow) (a,e) and
apoptotic cells (red arrow) were shown in orange. Myeloma (b,c,d) and WiDr  cells (f,g,h) treated with ZO, PR, and its
combination extract in IC50 value respectively, underwent a color change from green to orange indicating apoptosis.
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Figure 3. Expression of p53 on Myeloma and WiDr cancer cells. Untreated  cell (a,e), treatment with ZO, PR, and its combination on
Myeloma cells (b,c,d) and on WiDr cells (f,g,h) by immunohistochemistry method. The expression of p53 showed dark
colour (purple to black, red arrow) in the nuclei. The blue arrow showed cells without p53 expression. Cells were plated on
poly-L-lysine and stained with a p53-specific mAb.
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emergence of tumors in various experimental models of
carcinogenesis (Philip et al. 2004). Thus, inhibiting NFκB
signal is a strategy for treating cancer (Kim et al. 2008).
Piperine contained in PR protect cells from cancer by
binding proteins in the mitochondria to trigger apoptosis
without harming normal cells through enhanced activity
of antioxidant enzymes like superoxide dismutase,
catalase, and glutathione peroxidase (Selvendiran et al.
2003). Additionally, piperine may inhibit NFκB thereby
preventing the formation of tumors through TNF-α, so
angiogenesis does not occur (Pradeep & Kuttan 2004).
Given the different mechanism of action, the combination
of plants can enhance cytotoxic activity.
Figures 2 and 3 showed that ZO, PR, and the
combination extract induced apoptosis and p53 expression.
Apoptosis is characterized by distinct morphological
changes, including cell shrinkage, membrane blebbing,
chromatin condensation, DNA fragmentation, and the
formation of apoptotic bodies (Ward et al. 2008). The
process of apoptosis in Multiple Myeloma has problems
due to the occurrence of metastases in the bone marrow
which is the result of an imbalance in proliferation and
apoptosis processes (Scudla 2005). This study was similar
with study done by Abdullah et al. In 2010 which showed
that ginger extract at increasing concentrations induced
apoptosis, dose dependently, in colon cancer cells. [6]-
gingerol was associated with the modulation of p53 and
the involvement of mitochondrial signaling pathway in
B[a]P-induced mouse skin tumorigenesis (Nigam et al.
2009). Ginger can induce apoptosis via mitochondria
involving caspase-8, BID cleavage, cytochrome c release
and caspase-3 activation, such as curcumin. ZO and PR
can affect the activity of NFkB. A few NFκB regulated
genes, including Bcl-2, Bcl-XL, cIAP, TRAF1, and TRAF2,
have been reported to function primarily by blocking the
apoptotic pathways (Aggarwal & Shishodia 2006).
Research carried out by Rhode et al. (2007) showed
that red ginger can inhibit cell growth and modulate the
secretion angiogenic factor in ovarian cancer cells. In
addition, piperin can inhibit NFκB, which inhibits tumor
formation by TNF-α resulting in no occurrence of
angiogenesis (Pradeep & Kuttan 2004).
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